These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1587064)

  • 1. Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans.
    Funck-Brentano C; Bosco O; Jacqz-Aigrain E; Keundjian A; Jaillon P
    Clin Pharmacol Ther; 1992 May; 51(5):507-12. PubMed ID: 1587064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of chloroguanide and mephenytoin for the in vivo assessment of genetically determined CYP2C19 activity in humans.
    Partovian C; Jacqz-Aigrain E; Keundjian A; Jaillon P; Funck-Brentano C
    Clin Pharmacol Ther; 1995 Sep; 58(3):257-63. PubMed ID: 7554698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hydroxylation of omeprazole correlates with S-mephenytoin and proguanil metabolism.
    Kortunay S; Basci NE; Bozkurt A; Isimer A; Sayal A; Kayaalp SO
    Eur J Clin Pharmacol; 1997; 53(3-4):261-4. PubMed ID: 9476042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in Tanzanians.
    Skjelbo E; Mutabingwa TK; Bygbjerg Ib; Nielsen KK; Gram LF; Brøosen K
    Clin Pharmacol Ther; 1996 Mar; 59(3):304-11. PubMed ID: 8653993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvoxamine inhibits the CYP2C19-catalyzed bioactivation of chloroguanide.
    Jeppesen U; Rasmussen BB; Brøsen K
    Clin Pharmacol Ther; 1997 Sep; 62(3):279-86. PubMed ID: 9333103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of CYP2D6 and CYP2C19 activity in vivo in humans: a cocktail study with dextromethorphan and chloroguanide alone and in combination.
    Tennezé L; Verstuyft C; Becquemont L; Poirier JM; Wilkinson GR; Funck-Brentano C
    Clin Pharmacol Ther; 1999 Dec; 66(6):582-8. PubMed ID: 10613613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow chloroguanide metabolism in Tanzanians compared with white subjects and Asian subjects confirms a decreased CYP2C19 activity in relation to genotype.
    Herrlin K; Massele AY; Rimoy G; Alm C; Rais M; Ericsson O; Bertilsson L; Gustafsson LL
    Clin Pharmacol Ther; 2000 Aug; 68(2):189-98. PubMed ID: 10976550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proguanil metabolism is determined by the mephenytoin oxidation polymorphism in Vietnamese living in Denmark.
    Brøsen K; Skjelbo E; Flachs H
    Br J Clin Pharmacol; 1993 Aug; 36(2):105-8. PubMed ID: 8398577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by omeprazole of proguanil metabolism: mechanism of the interaction in vitro and prediction of in vivo results from the in vitro experiments.
    Funck-Brentano C; Becquemont L; Lenevu A; Roux A; Jaillon P; Beaune P
    J Pharmacol Exp Ther; 1997 Feb; 280(2):730-8. PubMed ID: 9023285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase.
    Birkett DJ; Rees D; Andersson T; Gonzalez FJ; Miners JO; Veronese ME
    Br J Clin Pharmacol; 1994 May; 37(5):413-20. PubMed ID: 8054246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Debrisoquin and S-mephenytoin hydroxylation phenotypes and CYP2D6 genotypes in an Estonian population.
    Marandi T; Dahl ML; Kiivet RA; Rägo L; Sjöqvist F
    Pharmacol Toxicol; 1996 May; 78(5):303-7. PubMed ID: 8737964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose kinetics of clomipramine: relationship to the sparteine and S-mephenytoin oxidation polymorphisms.
    Nielsen KK; Brøsen K; Hansen MG; Gram LF
    Clin Pharmacol Ther; 1994 May; 55(5):518-27. PubMed ID: 8181196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil.
    Kaneko A; Bergqvist Y; Takechi M; Kalkoa M; Kaneko O; Kobayakawa T; Ishizaki T; Björkman A
    J Infect Dis; 1999 Apr; 179(4):974-9. PubMed ID: 10068594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mephenytoin (cytochrome P450 2C 19) and dextromethorphan (cytochrome P450 2D6) polymorphisms in Saudi Arabians and Filipinos.
    Evans DA; Krahn P; Narayanan N
    Pharmacogenetics; 1995 Apr; 5(2):64-71. PubMed ID: 7663530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolism.
    Guttendorf RJ; Britto M; Blouin RA; Foster TS; John W; Pittman KA; Wedlund PJ
    Br J Clin Pharmacol; 1990 Apr; 29(4):373-80. PubMed ID: 2328190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous measurement of proguanil and its metabolites in human plasma and urine by reversed-phase high-performance liquid chromatography, and its preliminary application in relation to genetically determined S-mephenytoin 4'-hydroxylation status.
    Kusaka M; Setiabudy R; Chiba K; Ishizaki T
    Am J Trop Med Hyg; 1996 Feb; 54(2):189-96. PubMed ID: 8619446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic disposition of lansoprazole in relation to the S-mephenytoin 4'-hydroxylation phenotype status.
    Sohn DR; Kwon JT; Kim HK; Ishizaki T
    Clin Pharmacol Ther; 1997 May; 61(5):574-82. PubMed ID: 9164419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.
    Coller JK; Somogyi AA; Bochner F
    Br J Clin Pharmacol; 1999 Aug; 48(2):158-67. PubMed ID: 10417492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified high-performance liquid chromatographic method to measure both dextromethorphan and proguanil for oxidative phenotyping.
    Hoskins JM; Shenfield GM; Gross AS
    J Chromatogr B Biomed Sci Appl; 1997 Aug; 696(1):81-7. PubMed ID: 9300912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphic oxidative metabolism of proguanil in a Nigerian population.
    Bolaji OO; Sadare IO; Babalola CP; Ogunbona FA
    Eur J Clin Pharmacol; 2002 Nov; 58(8):543-5. PubMed ID: 12451432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.